Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. Patti Peeples, CEO of HealthEconomics.Com and Vice President of Evidence and Content at Scientist.com, the scientists discussed how IQVIA has taken on COVID-19. The CARE (COVID Active Research Experience) project was begun in April 2020 to track the symptoms that people experienced when becoming infected with COVID-19. Data from nearly 25,000 participants over the span of 10 months has since been collected. This registry fills an important gap in our understanding of COVID-19 by collecting data from non-hospitalized patients.
According to Dr. Dreyer, “In devising the CARE Registry, an essential building block was to look beyond claims-based medical encounters and focus on what people were actually experiencing, as well as their behaviors based on those experiences. We gather symptoms and couple this with self-reported medication use. Importantly, we’ve looked not only at prescription medications but also over-the-counter (OTC) medication use, as well as vitamin and supplement use. There is a great deal of interest in understanding whether these medications can serve as a modifiable factor, if you will, that could help one feel better, faster.” Learn more here.
(Source: HealthEconomics.Com, 2021)